PlainRecalls
FDA Drug Moderate Class II Terminated

Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-475-15

Reported: March 30, 2022 Initiated: March 14, 2022 #D-0708-2022

Product Description

Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-475-15

Reason for Recall

Defective container

Details

Units Affected
9,800 bags
Distribution
USA nationwide.
Location
Clarence, NY

Frequently Asked Questions

What product was recalled?
Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-475-15. Recalled by Athenex Pharma Solutions, LLC. Units affected: 9,800 bags.
Why was this product recalled?
Defective container
Which agency issued this recall?
This recall was issued by the FDA Drug on March 30, 2022. Severity: Moderate. Recall number: D-0708-2022.